Related Experiment Video
Updated: Dec 30, 2025
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.4K
CYSTIC PROLACTINOMA: A SURGICAL DISEASE?
AACE Clinical Case Reports
|January 23, 2020
Summary
Surgery may be a viable first-line treatment for cystic prolactinomas, especially when causing optic chiasm compression. This case highlights the need to carefully weigh medical versus surgical options for these complex pituitary tumors.
Area of Science:
- Endocrinology
- Neurosurgery
- Oncology
Background:
- Prolactinomas, pituitary tumors secreting prolactin, are typically managed with dopamine agonists.
- The efficacy of medical versus surgical treatment for predominantly cystic prolactinomas remains debated.
- This study presents a case where surgery was chosen as the initial therapy for a cystic prolactinoma.
Observation:
- A 26-year-old man presented with headaches and a 4-cm solid/cystic pituitary mass compressing the optic chiasm.
- Hormonal evaluation revealed hyperprolactinemia and central hypothyroidism.
- Despite initial medical management considerations, transsphenoidal resection was performed due to the cystic nature and mass effect.
Findings:
- The patient underwent successful transsphenoidal resection of the cystic prolactinoma.
- Postoperative treatment included bromocriptine to manage residual tumor.
- Complications included diabetes insipidus and secondary hypogonadism, underscoring potential surgical risks.
Implications:
- This case emphasizes that surgical intervention can be a primary treatment for cystic prolactinomas.
- Careful evaluation of cystic components and mass effect is crucial when deciding on treatment strategy.
- Individualized treatment planning is essential for optimal outcomes in prolactinoma management.
